

Tempus is a healthcare AI company that IPO'd a year ago and has had several failures to launch on the clearance above $70.
There is a key low volume node (LVN) at $57 that has served as a big level. The stock recently tested it and failed to breakdown.
Zooming in on the structure:

We've got a trendline break, and the stock is currently pulling back from a pivot zone around $64.
I am expecting that TEM, if it comes back into the $70 level, will break above it and momentum chasers will push it back up to $90 per share.
The Most Valuable Part of This Report Is Just Ahead
To continue reading this premium analysis, unlock full access below.
UpgradeUpgrade now and get the full article along with these benefits:
- Trade Setups That Work Risk-defined strategies built on insider activity, volatility behavior, momentum shifts, and liquidity dynamics.
- Macro Intelligence and Sector Rotations Early-stage insights into AI infrastructure, defense cycles, energy trends, and emerging tech opportunities.
- Priority Access to Our Best Ideas Deep-dive reports, bonus stock picks, and premium research you will not find in the free feed.
